First Time Loading...

Transcode Therapeutics Inc
NASDAQ:RNAZ

Watchlist Manager
Transcode Therapeutics Inc Logo
Transcode Therapeutics Inc
NASDAQ:RNAZ
Watchlist
Price: 1.775 USD 8.23% Market Closed
Updated: Jun 1, 2024

Transcode Therapeutics Inc
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Transcode Therapeutics Inc
Common Stock Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Transcode Therapeutics Inc
NASDAQ:RNAZ
Common Stock
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Common Stock
$18m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Stock
$1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Common Stock
$33.1B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Stock
$2.6m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Stock
$101.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Transcode Therapeutics Inc's Common Stock?
Common Stock
0 USD

Based on the financial report for Dec 31, 2023, Transcode Therapeutics Inc's Common Stock amounts to 0 USD.